It has previously been shown that some individuals with MDS have an underlying immunological problem (specifically IgA/IgG2 deficiency or functional antibody deficiency against pneumococcal vaccination) postulated to be a causal factor in early mortality [14]. This evidence concerns the gene CD79A and agammaglobulinemia.